2017-03-03 at 1:52 AM UTC
Thinking of hitting some up to make some sweet sweet dosh; anyone had any experience with?
Post last edited by Dearth at 2017-03-03T04:36:41.402033+00:00
2017-03-03 at 1:55 AM UTC
what the fuck are you on about.
2017-03-03 at 4:40 AM UTC
Speculation suggests the btc price bubble might burst soon; so I was thinking about doing clinical drug trials for money; and was wondering if anyone on this forum had had any experience with that sort of thing?
Does that read any better, Schizoid?
2017-03-03 at 4:42 AM UTC
ur gonna sign up and they're gonna give you ammonia analogs
The following users say it would be alright if the author of this
post didn't die in a fire!
2017-03-03 at 4:44 AM UTC
aldra
JIDF Controlled Opposition
seems pretty risky. would have to consider it on a case-by-case basis
2017-03-03 at 4:48 AM UTC
^that. It's somewhat like weighing the risk of being a whore and contracting an STD.
2017-03-03 at 8:42 AM UTC
Not asking anyone to oversee my decision; but just if anyone's interested, here are the details-
204856: This study is investigating a drug that has been developed as a potential treatment for Non-Alcoholic Fatty Liver Disease (NAFLD). Fat build up in the liver is responsible for liver disease which affects between 9% and 37% of the population in different parts of the world and is an increasing health burden to our society. In Australia, NAFLD is becoming an increasing problem in parallel with the growing epidemic of obesity. The best treatment for NAFLD is diet and exercise, however too few people can maintain lifestyle changes to maintain meaningful changes to their health. NAFLD can lead to the more severe form called Nonalcoholic Steatohepatitis (NASH) and ultimately to cirrhosis (scarring of liver), complete liver failure, or cancer. Currently there are no effective available treatments for these conditions.
A central mediator in the transition from NAFLD to NASH is thought to be increased fat in the form of triglycerides in the liver and other tissues. GSK3008356 works in a unique way by binding to and inhibiting a protein called DGAT1 which is a key protein involved in making triglycerides. It is hoped that GSK3008356 could be a better treatment option for those suffering from NAFLD and other related diseases.
2017-03-03 at 8:48 AM UTC
Why don't you just study, work hard and pursue gainful employment?
2017-03-03 at 11:41 AM UTC
Bill Krozby go listen to your helpless whine-ridden punk rock you microscopic bitch.
In other news; while I already have work, I'm looking to make a sweet few grand to press vinyl; which seems quite expensive these days.
2017-03-03 at 2:23 PM UTC
Thought about it but they generally require you to be a healthy non-smoker. I am neither
